<page><tag>3</tag><title>Pfizer has drugs in line to replace expired patents</title><text>Pfizer Inc. is on schedule to complete the filing of 20 new drug applications by the end of 2006 as it confronts patent expirations affecting \$14 billion in sales, CEO Hank McKinnell said Tuesday.</text></page>